Peter Trinder

Peter Trinder is a seasoned professional in regulatory affairs and scientific research, currently serving as Senior Director of Global Regulatory Affairs at Veracyte, Inc. since January 2022. Previous roles include Global Regulatory Affairs Director at Bruker Daltonics and Regulatory Affairs & Business Development Director at AESKU.Diagnostics, where responsibilities encompassed international regulatory compliance and project management in vitro diagnostics. Peter also held positions as CEO at Thymed GmbH, where the focus was on immune monitoring and epitope discovery, and as Manager of Business Development at Glycotope/Nemod Immuntherapie. With a background in research, including a postdoctoral position at Johannes Gutenberg University and a PhD in Veterinary Immunology from the London School of Hygiene and Tropical Medicine, Peter Trinder brings extensive expertise in scientific liaison, regulatory strategy, and product development to the biotechnology sector.